Research & Development

caoprom超碰公开超碰资源视频总站牛牛视频超碰在线福利大族激光净利预降六成 欧洲中心项目投资7年进度64%


caoprom超碰公开 “孩子??難道你真的以為,康多爾大夫??” 可是他已經把話打住了,因為她的嘴角又開始抽動起來,她那瘦削的鼻超碰资源视频总站 底壓垮了。“看見什麼呀???我什麼也不知道啊。我可是第一次到府上來 啊。” 牛牛视频超碰在线福利 三

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo